In August of 2022, the American College of Cardiology (ACC) released an Expert Consensus Decision Pathway with new guidance for lowering LDL cholesterol. An Expert Consensus Decision Pathway is a guiding tool for medical [...]
Look at the incredible reach we had together! Together, we reached millions of people on multiple social media platforms and on national TV and radio in September. This outreach raises [...]
Lower Your Cholesterol to Help Decrease Your Risk for Heart Disease The Family Heart Foundation gratefully acknowledges the generous support of our sponsors for this LDL Cholesterol [...]
Why We Have Cholesterol Education Month When we are born, our arteries are clear and healthy. They carry blood, oxygen, and nutrients from our hearts to every part of our [...]
March 24th was the first ever Lipoprotein(a) Awareness Day, and my conversations about it went something like this: Me: Did you know today is Lp(a) Awareness Day? Friend: What’s that? Me: Elevated Lp(a) [...]
What is the impact of early diagnosis and appropriate treatment on disease management and longevity for individuals with familial hypercholesterolemia (FH) over the course of 45 years? I answered [...]
The Institute for Clinical and Economic Review (ICER) – an organization that produces reports that analyze the cost effectiveness of drugs and other medical services – has highlighted [...]
(BPT) One in four deaths in the U.S. is caused by heart disease. More than 610,000 people die of heart disease in the U.S. every year, making it [...]
A Time of Hope for FH Patients Today, Casey Walsh, FH Advocate for Awareness, shares her insights on the new year, birthdays, and what each year additional year living [...]
Copyright © - 2025 All Rights Reserved Family Heart Foundation
Early diagnosis and treatment can mean years, even decades of life for someone with impacted by familial hypercholesterolemia (FH) and lipoprotein(a), also known as Lp(a).
Yet a majority of people with these inherited disorders haven’t even been diagnosed.
Your gift allows us to continue to engage the research, advocacy, and education that helps individuals with FH, HoFH, or elevated Lp(a) get the vital medical care that they need.
